Stay updated on Risankizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Risankizumab in Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedA new software revision label, v3.6.6, was applied, replacing the previous v3.6.5. This indicates a deployment update to the platform.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe revision label was updated from v3.6.4 to v3.6.5, indicating a small maintenance/update. No core content or user-facing elements appear to be altered.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page revision updated from v3.6.3 to v3.6.4, indicating a minor internal update to the page version. This does not alter the displayed study information or user-facing content.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor update to the page. It does not reflect changes to the study data or displayed details.SummaryDifference0.0%

- Check71 days agoChange DetectedThe site’s version tag was updated from v3.6.0 to v3.6.2, indicating a minor platform update. There is no indication that study content or page details have changed.SummaryDifference0.0%

- Check85 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new help/navigation sections are added (How to Read a Study Record, Common Questions, How to Join a Study), with a formatting tweak to the Intervention/Treatment label and a revision tag updated to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Risankizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.